Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glioma
87%
Differential Mobility Spectrometry
62%
Isocitrate Dehydrogenase 1 (IDH1)
62%
Poor Outcome
61%
Tumor
59%
Pediatric Brain Tumor
58%
Cell-free DNA (cfDNA)
54%
Central Nervous System Tumors
43%
Glioblastoma
40%
Radiotherapy
34%
Pilocytic Astrocytoma
32%
Brain Tumor
32%
Liquid Biopsy
31%
Low Input
31%
Medulloblastoma
31%
Spectrometry Analysis
29%
University Hospital
28%
Surgery Treatment
27%
Adjuvant Therapy
27%
Timing of Surgery
27%
Clinical Association
27%
Multicenter Cohort Study
27%
Atypical Teratoid/rhabdoid Tumor
27%
Childhood Cancer Predisposition
27%
Classification Accuracy
27%
CNS Tumors
27%
Tumor Characterization
27%
Association Analysis
27%
Fibroblast Growth Factor Receptor 1 (FGFR1)
27%
Fibroblast Growth Factor Receptor 3 (FGFR3)
27%
Ependymoma
27%
Myeloid Cells
27%
Non-canonical
27%
Brain Tumor Microenvironment
27%
Cell-free DNA Screening
27%
Patient Outcomes
27%
Group 3 Medulloblastoma
27%
Diathermy Smoke
27%
Carbonic Anhydrase Inhibitors
27%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
27%
Astrocytic Glioma
27%
Ultra-low
27%
Tumor Detection
27%
Differential Ion Mobility Spectrometry
27%
Genomic Analysis
27%
DNA Methylome
27%
Organoids
27%
Patient-derived
27%
Robust Classification
27%
Cell Subsets
27%
Medicine and Dentistry
Ganglioglioma
100%
Neoplasm
46%
Glioblastoma
40%
Pilocytic Astrocytoma
34%
Intracranial Tumor
31%
Stereotypic Movement Disorder
27%
Fibroblast Growth Factor Receptor 1
27%
Cancer Susceptibility
27%
Pediatric Brain Tumor
27%
Cerebrospinal Fluid
27%
Patient Referral
27%
DNA Sequencing
27%
Cell-Free DNA
27%
Childhood Cancer
27%
Adjuvant Therapy
27%
Diathermy
27%
Isocitrate Dehydrogenase
27%
Ependymoma
27%
Fibroblast Growth Factor Receptor 3
27%
Liquid Biopsy
22%
Tumor
21%
Hazard Ratio
20%
Epileptic Seizure
20%
Cognitive Defect
20%
Isocitric Acid
20%
Pediatrics
20%
Whole Genome Sequencing
18%
Ex Vivo
13%
Dizziness
13%
Paresis
13%
Headache
13%
Neurosurgery
13%
Central Nervous System Tumor
13%
Mesenchymal-Epithelial Transition
10%
Radiation Therapy
6%
Meningioma
6%
Multivariate Analysis
6%
Electronic Patient Record
6%
Metastatic Carcinoma
6%
Health Care Cost
6%
Proportional Hazards Model
6%
Tumor Bleeding
6%
Speech Disorder
6%
Brain Tissue
6%
Prognostic Factor
6%
Long Term Survival
6%
Median Survival Time
6%
Oncology
6%
Hypoxia Inducible Factor
5%
Clinical Significance
5%
